Invention Grant
- Patent Title: Thienopyrazine inhibitors of IRAK4 activity
-
Application No.: US15557206Application Date: 2016-03-07
-
Publication No.: US10040802B2Publication Date: 2018-08-07
- Inventor: Jongwon Lim , Michael D. Altman , Craig R. Gibeau
- Applicant: MERCK SHARP & DOHME CORP.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Matthew A. Leff; Laura Ginkel
- International Application: PCT/US2016/021125 WO 20160307
- International Announcement: WO2016/144849 WO 20160915
- Main IPC: C07D495/04
- IPC: C07D495/04 ; C07D519/00 ; A61K45/06 ; A61K31/551 ; A61K31/55 ; A61K31/4985
Abstract:
The present invention relates to thienopyrazine inhibitors of IRAK4 of formula (I) and provides compositions comprising such inhibitors, as well as methods therewith for treating IRAK4-mediated or -associated conditions or diseases.
Public/Granted literature
- US20180051035A1 THIENOPYRAZINE INHIBITORS OF IRAK4 ACTIVITY Public/Granted day:2018-02-22
Information query
